Toluidine blue-based photodynamic therapy for inducing...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5415 (2006.01) A61K 41/00 (2006.01) A61P 17/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2330995

Photodynamic therapy is a new therapeutic modality in dermatology involving the administration of a photosensitizer and its subsequent activation with visible light to destroy or alter the function of target cells or tissues. Toluidine blue i(TBO) is a non-toxic cationic dye of the phenothiazine family. We show that toluidine blue has potent phototoxic effect against malignant human T lymphocytes in vitro. Apoptosis (DNA fragmentation and cell death) was rapidly induced by TBO in Jurkat cells. Psoriasis is an inflammatory skin disease in which the role of T lymphocytes is well established. Extensive psoriasis could be an ideal indication for photodynamic therapy with whole body light exposure after systemic photosensitizer administration. The use of human psoriatic skin-grafted SCID mice has been proven useful and reliable in the study of novel therapeutic agents. The goal of this project is two-fold: 1) to determine the dose-range of systemically administered toluidine blue and light inducing a phototoxic reaction in mice 2) determine whether we can induce clinical remission or improvement using TBO-based PDT in SCID mice. Mice are administered TBO and irradiated with light. Psoriatic skin response to treatment is followed with serial clinical assessments. A dose in the µg range of TBO is to be administered systemically to psoriatic patients. Further, the potent apoptotic effect of TBO on activated lymphocytes T is indicative of a role of TBO for bone marrow purging. A concentration in the µmolar range of TBO is to be contacted with bone marrow cells.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Toluidine blue-based photodynamic therapy for inducing... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Toluidine blue-based photodynamic therapy for inducing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Toluidine blue-based photodynamic therapy for inducing... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2031403

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.